Fibromyalgia is a syndrome that is frustrating to both patients and physicians. Symptoms include chronic widespread pain and muscle tenderness often accompanied by fatigue, problems with sleep, and ...

The Therapeutic Goods Administration (TGA), Australia's regulatory body for therapeutic products, granted Pierre Fabre Médicament's milnacipran market authorisation for the treatment of fibromyalgia ( ...

Fibromyalgia is a long-term condition characterized by widespread pain, fatigue, and cognitive difficulties. Management involves a multifaceted approach, combining medication, exercise, and therapies ...